Angeles Investment Advisors, LLC Bristol Myers Squibb CO Transaction History

Angeles Investment Advisors, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$47.98 - $54.4 $48,843 - $55,379	1,018 Added 18.05%	6,659 $361,000
Q4 2023 Feb 13, 2024	BUY	$48.48 - $57.85 $3,781 - $4,512	78 Added 1.4%	5,641 $289,000
Q3 2023 Nov 09, 2023	SELL	$57.89 - $64.73 $12,793 - $14,305	-221 Reduced 3.82%	5,563 $322,000
Q2 2023 Aug 10, 2023	BUY	$63.71 - $70.74 $79,892 - $88,707	1,254 Added 27.68%	5,784 $369,000
Q1 2023 May 15, 2023	BUY	$65.71 - $74.53 $297,666 - $337,620	4,530 New	4,530 $313,000
Q1 2022 May 16, 2022	SELL	$61.48 - $73.72 $397,468 - $476,599	-6,465 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$53.63 - $62.52 $29,925 - $34,886	558 Added 9.45%	6,465 $403,000
Q3 2021 Nov 15, 2021	BUY	$59.17 - $69.31 $44,377 - $51,982	750 Added 14.54%	5,907 $350,000
Q2 2020 Aug 13, 2020	SELL	$54.82 - $64.09 $42,814 - $50,054	-781 Reduced 13.15%	5,157 $303,000
Q1 2020 May 06, 2020	BUY	$46.4 - $67.43 $13,595 - $19,756	293 Added 5.19%	5,938 $366,000
Q4 2019 Jan 29, 2020	BUY	$49.21 - $64.19 $3,051 - $3,979	62 Added 1.11%	5,645 $362,000
Q3 2019 Nov 01, 2019	BUY	$42.77 - $50.71 $238,784 - $283,113	5,583 New	5,583 $283,000

2,425

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Angeles Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Angeles Investment Advisors, LLC with notifications on news.